Name | norgestimate |
---|---|
Synonyms |
(3E,8R,9S,10R,13S,14S,17R)-13-Ethyl-17-ethynyl-3-(hydroxyimino)-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate
(+)-13-Ethyl-17-hydroxy-18,19-dinor-17a-pregn-4-en-20-yn-3-one Oxime Acetate (Ester) d-17beta-acetoxy-13beta-ethyl-17alpha-ethinyl-gon-4en-3-one oxime dexnorgestrelacetime Norgestimat Norgestimate NORGESTIMATE,USP STANDARD levonorgestrel acetate 3-oxime (3E,8R,9S,10R,13S,14S,17R)-17-Ethinyl-13-ethyl-3-(hydroxyimino)-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-ylacetat acétate de (3E,8R,9S,10R,13S,14S,17R)-13-éthyl-17-éthynyl-3-(hydroxyimino)-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tétradécahydro-1H-cyclopenta[a]phénanthrén-17-yle |
Description | Norgestimate, a synthetic progesterone analog, is an orally active progestin with highly selective progestational activity and minimal androgenicity. Norgestimate is used for an oral contraceptive[1][2]. |
---|---|
Related Catalog | |
In Vitro | Norgestimate is converted to at least two active metabolites: levonorgestrel 3-oxime (deacetylated norgestimate; norelgestromin) and levonorgestrel[1]. |
References |
[1]. Stanczyk FZ, et al. All progestins are not created equal. Steroids. 2003 Nov;68(10-13):879-90. |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 497.9±45.0 °C at 760 mmHg |
Melting Point | 216ºC |
Molecular Formula | C23H31NO3 |
Molecular Weight | 369.497 |
Flash Point | 254.9±28.7 °C |
Exact Mass | 369.230408 |
PSA | 58.89000 |
LogP | 5.00 |
Vapour Pressure | 0.0±2.9 mmHg at 25°C |
Index of Refraction | 1.611 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Symbol |
GHS07, GHS08 |
---|---|
Signal Word | Warning |
Hazard Statements | H302-H315-H319-H361fd |
Precautionary Statements | P281-P305 + P351 + P338 |
Hazard Codes | Xn |
Risk Phrases | 63-22-36/38-62 |
Safety Phrases | 26-36/37 |
RIDADR | NONH for all modes of transport |
RTECS | JF7976000 |
~85% 35189-28-7 |
Literature: RICHTER GEDEON VEGYESZETI GYAR R.T. Patent: WO2005/868 A1, 2005 ; Location in patent: Page/Page column 5 ; |
Precursor 1 | |
---|---|
DownStream 0 |